Herantis Pharma selected for European Innovation Council (EIC) grant of €2.5 million
Herantis Pharma Plc, Company release, insider information, 19 December 2022 at 5:28 p.m. EET The EIC will, pending final negotiation, grant Herantis with EUR 2.5 million through their prestigious EIC Accelerator, with the option to receive additional funding through an equity investment. Herantis Pharma Plc ("Herantis") developing disease-modifying therapies for Parkinson’s disease, announced today that it has been invited to negotiate a grant agreement with EIC. This grant will fund the further development of Herantis’ lead product HER-096 for Parkinson’s disease. Herantis’